Completion of the licensing of Frova™ to Endo
18 August 2004
Vernalis plc (LSE:VER, Nasdaq: VNLS) today announces that, all conditions now being satisfied, the North American license agreement for Frova™ with Endo, announced on 15 July 2004, completed on 17 August 2004.
----ends----
Enquiries:
Vernalis plc
Simon Sturge, Chief Executive Officer
Tony Weir, Chief Financial Officer
+44 (0)118 977 3133
Brunswick Group (for analyst, financial media
enquiries)
Jon Coles; Wendel Carson
+44 (0)20 7404 5959
